Dr Reddys Laboratories Share Price Today - Live Blog for September 26, 2025

With a -0.04% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,252.40. The stock is currently trading at a PE of 18.7300, while the industry PE is 34.9706, prompting investors to assess its value proposition.

Following a noteworthy 0.17% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,253.75. When it comes to valuation, this stock has a PE ratio of 18.7300, with the industry PE ratio at 34.9706.

The share price of Dr Reddys Laboratories Ltd recently experienced a positive upturn, resulting in a 0.04% increase. Presently, it is actively trading at ₹1,253.55.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.24% in its share price, and it currently trades at ₹1,253.35 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

After a notable 0.38% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,257.30. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

Dr Reddys Laboratories Ltd witnessed a -0.19% decrease in its share price, and it is currently trading at ₹1,252.20. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 18.7300, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.11% drop, and it's now trading at ₹1,252.95 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

Dr Reddys Laboratories Ltd observed a -0.06% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,254.90. The stock has a PE ratio of 18.7300, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd share price has declined by -0.03%, and it's currently trading at ₹1,255.35. The stock maintains a PE of 18.7300, while the industry PE is 34.9706, prompting discussions about its valuation.

The stock of Dr Reddys Laboratories Ltd suffered a -0.22% decline, and it currently trades at ₹1,257.20 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

The stock of Dr Reddys Laboratories Ltd suffered a -0.05% drop, and it's now trading at ₹1,259.60 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

Dr Reddys Laboratories Ltd's shares experienced a 0.09% uptick, and they are currently valued at ₹1,260.20, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

Dr Reddys Laboratories Ltd witnessed a notable 0.09% surge in its share price and is presently trading at ₹1,260.20, captivating the attention of market participants.

The stock of Dr Reddys Laboratories Ltd is making significant strides, boasting a 0.09% increase and currently trading at ₹1,260.20 per share. This upward trajectory is turning heads in the market.

Demonstrating a commendable 0.09% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,260.20. In terms of valuation, the stock maintains a PE ratio of 18.7300, while the industry PE ratio stands at 34.9706.

The share price of Dr Reddys Laboratories Ltd plunged by -0.21%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,259.50, but investors are assessing whether this is a temporary dip or a long-term trend.

Following a noteworthy 0.41% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,262.85. When it comes to valuation, this stock has a PE ratio of 18.7300, with the industry PE ratio at 34.9706.

After a -0.17% decline, Dr Reddys Laboratories Ltd shares are now trading at ₹1,258.10. The stock has a PE ratio of 18.7300, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

After a significant 0.45% gain, Dr Reddys Laboratories Ltd's shares are now valued at ₹1,260.25 in the current market. This upward movement is attracting attention from both retail and institutional investors.

With a -0.37% decrease, Dr Reddys Laboratories Ltd's share price is now ₹1,253.20. Investors should examine the factors driving this decline. The stock's PE ratio is 18.7300, whereas the industry PE ratio stands at 34.9706.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.54%, reaching a current market price of ₹1,257.85. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

The share price of Dr Reddys Laboratories Ltd plunged by -0.54%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,257.85, but investors are assessing whether this is a temporary dip or a long-term trend.

Dr Reddys Laboratories Ltd share price surged by 0.00%. With its current market price standing at ₹1,263.55 per share, this stock is garnering increased attention from the investment community.

Dr Reddys Laboratories Ltd's share price has fallen by -0.11%, a situation worth noting. At present, the stock is trading at ₹1,266.15. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 18.7300, while the industry PE ratio is 34.9706.

The stock of Dr Reddys Laboratories Ltd is facing a -0.11% decline and is currently trading at ₹1,266.15 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

Dr Reddys Laboratories Ltd stock price decreased by -0.11%, with the current market value at ₹1,266.15 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

The stock of Dr Reddys Laboratories Ltd is facing a -0.12% decline and is currently trading at ₹1,268.05 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

The share price of Dr Reddys Laboratories Ltd experienced a -0.06% slump and is currently trading at ₹1,270.35. While the stock maintains a PE ratio of 18.7300, the industry PE is 34.9706, raising questions about valuation.

Dr Reddys Laboratories Ltd's share price has experienced a notable 0.87% upswing, and it's currently trading at ₹1,272.10 per share. Investors are closely watching this development.

Dr Reddys Laboratories Ltd's stock price surged by 0.03%, reaching the current market value of ₹1,260.15 per share. This surge is a testament to the stock's recent performance.

The share price of Dr Reddys Laboratories Ltd experienced an impressive 5.00% upswing and is currently trading at ₹1,260.00, indicating strong market sentiment.